Overview
Polski Bank Komórek Macierzystych is the largest stem cell bank in Europe, specializing in the collection and storage of umbilical cord blood. The bank provides stem cell services that are utilized in the treatment of approximately 80 oncological and hematological diseases. Additionally, it collaborates with over 1,500 hospitals and has stored over 1,000,000 samples.
News
PBKM signed a cooperation agreement with ArThec in advanced therapy development
Conference: Cell therapies without secrets
PBKM at this year's EBMT 2026 meeting
Kacper's story – stem cell therapy (MSC)
Umbilical cord blood: Position of the Polish Society of Pediatric Oncology and Hematology (2025)
Expansion of umbilical cord blood available in Europe!
Industry
Bank accounts
Registered as a VAT taxpayer on 2002-06-20. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 8, 2026 | Merger registered | |
| Jan 11, 2023 | Transformation |
Public aid
4 public aid cases recorded, with a total value of $3,070,577.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 21, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $59,840$59,840 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Mar 15, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,431$1,431 | Marszałek Mazowiecki | |
| Oct 11, 2017 | Aid for research and development projects: experimental development | $1.8M$1,774,257 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, or a commercial proxy acting jointly with a member of the management board, are authorized to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Famicord Ag | 93,387 | $1,261,304.70 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Klaus Röhrig (49)  | Pośrednia kontrola nad podmiotem dominującym wobec spółki | |
Florian Schuhbauer (51)  | Pośrednia kontrola nad podmiotem dominującym wobec spółki |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
CryoprofilS.A. | — | 100% | ||
Diagnostica Bank Komórek Macierzystychsp. z o.o. | 105,888.71 USD | 100% | ||
Novbank Komórek Macierzystychsp. z o.o. | 13,506.21 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| American Heart Of PolandS.A. | $326,403,314.92 | ahop.pl | ||
| Mazowiecki Szpital Onkologicznysp. z o.o. | $72,929,509.74 | szpitalonkologiczny.pl | ||
| Szpital Czerniakowskisp. z o.o. | $53,133,134.99 | szpitalczerniakowski.waw.pl | ||
| Centermed Poznańsp. z o.o. | $3,656,726.26 | centermed.pl | ||
| Info-Pat sp. z o.o.sp. k. | $1,930,368.97 | info-pat.poznan.pl | ||
| Masdiagsp. z o.o. | $1,691,863.39 | masdiag.pl | ||
| Medigensp. z o.o. | $501,900.52 | medigen.pl | ||
| Medica Komórki Macierzystesp. z o.o. | $177,526.67 | medicastemcells.com | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-13 | PKD change (Removed: 63.11.Z, 72.11.Z, 72.19.Z, 86.90, 86.90.E; Added: 70.10.A, 72.10.Z, 85.59.D, 86.91.B, 86.99.D) | |
| 2023-01-03 | Entered in the register |
FAQ
Last updated: 2026-07-24